Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06462885 · ClinicalTrials.gov registry record
Living Alone is Predictive of Non-home Discharge Following Elective Total Hip Arthroplasty: a Matched-pairs Cohort Analysis
A clinical trial, sponsored by University of Virginia.
- Completed
- Registry status
- 5,677
- Enrollment target
NCT06462885: Completed study, sponsored by University of Virginia.
NCT06462885 is a clinical trial that has completed, run by University of Virginia. The registered enrollment target is 5,677 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06462885 has completed, sponsored by University of Virginia.
- COMPLETED
- Registry status
- 5,677 participants
- Enrollment target
Study Summary
The goal of this observational study is to assess the effect of living alone on total hip arthroplasty thirty-day outcomes. The main questions it aims to answer are: Is living alone associated with discharge disposition (home versus non-home)? Is living alone associated with greater incidences of secondary adverse events? Participants will be sampled from the 2021 American College of Surgeons National Surgical Quality Improvement Program
Primary Outcome
Home versus non-home
Interventions
- BEHAVIORAL home support, hiving alone
- BEHAVIORAL home support, living with others
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5,677 participants |
| Start Date | 2021-01-01 |
| Est. Completion | 2022-01-30 |
What the finished NCT06462885 record still lists
NCT06462885 is an observational study that tracks outcomes without assigning an intervention. Its 5,677 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 2 interventions - of which home support, hiving alone is the first listed.
NCT06462885 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06462885 about?
NCT06462885 is a clinical study titled "Living Alone is Predictive of Non-home Discharge Following Elective Total Hip Arthroplasty: a Matched-pairs Cohort Analysis". The goal of this observational study is to assess the effect of living alone on total hip arthroplasty thirty-day outcomes. The main questions it aims to answer are: Is living alone associated with discharge disposition (home versus non-home)? Is living alone associated with greater incidences of s...
What is the current status of trial NCT06462885?
This trial is currently completed. The enrollment target is 5,677 participants. The study started on 2021-01-01. Estimated completion is 2022-01-30.
What interventions are being tested in trial NCT06462885?
The interventions under investigation include: home support, hiving alone (BEHAVIORAL), home support, living with others (BEHAVIORAL).
Who is sponsoring clinical trial NCT06462885?
This trial is sponsored by University of Virginia, which has 449 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04983875 · 5,708 participants · NA
Mammography and Breast Arterial Calcification: An Information-Sharing Trial
- NCT06627335 · 5,621 participants
An Observational Retrospective Cohort Study Being Conducted in Women With Atopic Dermatitis Exposed to Ruxolitinib Cream Versus Topical Corticosteroids During Pregnancy: A US Claims Database Analysis
- NCT05636176 · 5,600 participants · Phase 3
A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Heart Failure and Inflammation
- NCT06981598 · 5,586 participants · NA
Prevention of Psychological Health Problems Via Integrated Operational Support
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI